Literature DB >> 28708482

Metabolic surgery for treating type 2 diabetes mellitus: Now supported by the world's leading diabetes organizations.

Philip R Schauer1, Zubaidah Nor Hanipah2,3, Francesco Rubino4.   

Abstract

The term metabolic surgery describes bariatric surgical procedures used primarily to treat type 2 diabetes and related metabolic conditions. Originally, bariatric surgery was used as an alternative weight-loss therapy for patients with severe obesity, but clinical data revealed its metabolic benefits in patients with type 2 diabetes. Metabolic surgery is more effective than lifestyle or medical management in achieving glycemic control, sustained weight loss, and reducing diabetes comorbidities. Perioperative adverse events are similar to other gastrointestinal surgeries. New guidelines for type 2 diabetes expand use of metabolic surgery to patients with a lower body mass index.
Copyright © 2017 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28708482     DOI: 10.3949/ccjm.84.s1.06

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  9 in total

1.  Thyroid Homeostasis After Bariatric Surgery in Obese Cases.

Authors:  Feyzi Gokosmanoglu; Erkan Aksoy; Attila Onmez; Hasan Ergenç; Sibel Topkaya
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

2.  Consistent gut bacterial and short-chain fatty acid signatures in hypoabsorptive bariatric surgeries correlate with metabolic benefits in rats.

Authors:  Paulette Mukorako; Natacha Lemoine; Laurent Biertho; Stéfane Lebel; Marie-Claude Roy; Julie Plamondon; André Tchernof; Thibault V Varin; Fernando F Anhê; David H St-Pierre; André Marette; Denis Richard
Journal:  Int J Obes (Lond)       Date:  2021-10-22       Impact factor: 5.095

Review 3.  Bariatric Surgery and Precision Nutrition.

Authors:  Carolina F Nicoletti; Cristiana Cortes-Oliveira; Marcela A S Pinhel; Carla B Nonino
Journal:  Nutrients       Date:  2017-09-06       Impact factor: 5.717

Review 4.  Epigenetic contribution to obesity.

Authors:  Meriem Ouni; Annette Schürmann
Journal:  Mamm Genome       Date:  2020-04-11       Impact factor: 2.957

5.  DNA methylation screening after roux-en Y gastric bypass reveals the epigenetic signature stems from genes related to the surgery per se.

Authors:  C F Nicoletti; M A S Pinhel; A Diaz-Lagares; F F Casanueva; A Jácome; V C Pinhanelli; B A P de Oliveira; A B Crujeiras; C B Nonino
Journal:  BMC Med Genomics       Date:  2019-05-27       Impact factor: 3.063

Review 6.  Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms.

Authors:  Yu Ji; Hangil Lee; Shawn Kaura; James Yip; Hao Sun; Longfei Guan; Wei Han; Yuchuan Ding
Journal:  Biomolecules       Date:  2021-10-26

Review 7.  Type 2 diabetes, gut microbiome, and systems biology: A novel perspective for a new era.

Authors:  Yoscelina Estrella Martínez-López; Diego A Esquivel-Hernández; Jean Paul Sánchez-Castañeda; Daniel Neri-Rosario; Rodolfo Guardado-Mendoza; Osbaldo Resendis-Antonio
Journal:  Gut Microbes       Date:  2022 Jan-Dec

Review 8.  Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management.

Authors:  Ahmad Alkhatib; Catherine Tsang; Ali Tiss; Theeshan Bahorun; Hossein Arefanian; Roula Barake; Abdelkrim Khadir; Jaakko Tuomilehto
Journal:  Nutrients       Date:  2017-12-01       Impact factor: 5.717

9.  New Metrics to Assess Type 2 Diabetes After Bariatric Surgery: The "Time-Within-Remission Range".

Authors:  Ana de Hollanda; Albert Lecube; Miguel Angel Rubio; Enric Sánchez; Núria Vilarrasa; José Gregorio Oliva; María Luisa Fernández-Soto; Jordi Salas-Salvadó; María D Ballesteros-Pomar; Andreea Ciudin; Ferran Torres; Concepción Vidal; María José Morales; Sergio Valdés; Silvia Pellitero; Inka Miñambres; Lluís Masmiquel; Albert Goday; Lorena Suarez; Liliam Flores; Marta Bueno; Assumpta Caixàs; Irene Bretón; Rosa Cámara; Romina Olbeyra; Rona Penso; María José de la Cruz; Andreu Simó-Servat; Francisca María Pereyra-García; Elena Teresa López-Mezquita; Anna Gils; Enzamaria Fidilio; Orosia Bandrés; Ángel Martínez; Jose Abuín; Montserrat Marques-Pamies; Laura Tuneu; Magdalena Arteaga; Olga Castañer; Fernando Goñi; Cristina Arrizabalaga; Manuel Antonio Botana; Alfonso Calañas; Ángel Rebollo
Journal:  J Clin Med       Date:  2020-04-09       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.